X4 Pharmaceuticals (XFOR) Return on Capital Employed Growth (3y) (2021 - 2025)
X4 Pharmaceuticals (XFOR) Return on Capital Employed Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 4,853.00 |
| 10 | X4 Pharmaceuticals | 167.69 Mn | -49.36 Mn | 2.20 Mn | 3,490.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,490.00 |
| Sep 30, 2025 | 4,370.00 |
| Jun 30, 2025 | 1,993.00 |
| Mar 31, 2025 | 8,704.00 |
| Dec 31, 2024 | 5,307.00 |
| Sep 30, 2024 | 4,686.00 |
| Jun 30, 2024 | 3,774.00 |
| Mar 31, 2024 | -5,597.00 |
| Dec 31, 2023 | -2,665.00 |
| Sep 30, 2023 | -3,035.00 |
| Jun 30, 2023 | -4,097.00 |
| Mar 31, 2023 | -4,460.00 |
| Dec 31, 2022 | -3,693.00 |
| Sep 30, 2022 | -8,975.00 |
| Jun 30, 2022 | -8,406.00 |
| Mar 31, 2022 | 7,412.00 |
| Dec 31, 2021 | 6,412.00 |
| Sep 30, 2021 | -1,863.00 |
| Jun 30, 2021 | -789.00 |
| Mar 31, 2021 | -1,865.00 |